paclitaxel has been researched along with Cancer of Gastrointestinal Tract in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 13 (39.39) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Maeda, O; Shimokata, T | 1 |
| Joshi, SS; Kindler, HL; Sharma, MR | 1 |
| Li, J; Liu, H; Liu, J; Qiao, Y; Sun, J; Wang, K; Wu, Y; Yang, A; Yu, Y; Zhang, R; Zhang, X; Zhao, X | 1 |
| Bois, MC; Chakrabarti, S; Chandrasekharan, C; Dong, H; Foster, NR; Graham, RP; Kankeu Fonkoua, LA; Kasi, PM; Liu, AJ; Markovic, SN; Maus, RL; Nevala, WK; Pitot, HC; Ross, HJ; Sonbol, MB; Starr, JS; Villasboas, JC; Weiss, M; Wu, TT; Yoon, HH | 1 |
| Bapat, S; Desai, B; Dichwalkar, T; Jasani, N; Pancholi, P; Patel, S; Sehdev, V; Yellepeddi, VK | 1 |
| Fan, H; Li, J; Lu, P; Qin, Y; Xu, L | 1 |
| Akin, S; Kas Guner, C | 1 |
| Appelman, HD; Beer, DG; He, L; Kang, X; Kuick, R; Li, M; Li, W; Ma, X; Nancarrow, DJ; Pang, Z; Sturm, MB; Wang, TD; Zhang, C; Zhang, W; Zhang, Y; Zhou, J | 1 |
| Cheng, XL; Feng, YJ; Fu, AR; Li, XJ; Song, RF; Wang, YH; Xiong, Y | 1 |
| Garrido-Laguna, I; Patel, S; Reese, Z; Stenehjem, DD | 1 |
| Aquino, JB; Malvicini, M; Mazzolini, G | 1 |
| Karam, A; Kong, CS; O'Keefe, MC; Westhoff, GL; Wheeler, L | 1 |
| Lee, JR; Oh, PJ | 1 |
| Deme, D; Telekes, A | 1 |
| Cohen, L; Driver, L; Eng, C; Lopez, G; Lyle, R; McQuade, J; Novy, D; Prinsloo, S; Ramondetta, L | 1 |
| Choi, M; Gadgeel, SM; Heilbrun, LK; Jiang, PQ; Smith, DW | 1 |
| Ilson, DH; Kelsen, DP; Kepler, S; O'Reilly, E; Radovich, D; Saltz, LB; Schrag, D; Schwartz, G; Tew, WP | 1 |
| Han, J; Jang, SI; Kim, HG; Kim, JH; Lee, DK; Lee, SJ; Park, SH; Rhee, K; Shin, IH; You, JW | 1 |
| Shah, T | 1 |
| Abrams, RA; Regine, WF; Rich, TA; Safran, H; Willett, CG | 1 |
| Mohamed, F; Sugarbaker, PH | 1 |
| Hiro, J; Hosono, A; Inoue, Y; Kusunoki, M; Miki, C; Narita, Y; Ojima, E; Toiyama, Y; Watanabe, H | 1 |
| Ajani, JA; Ilson, DH; Kelsen, DP | 1 |
| Benson, AB; Einzig, AI; Lipsitz, S; Wiernik, PH | 1 |
| Rougier, P | 1 |
| Ogawa, M | 1 |
| Aapro, MS | 1 |
| Sasaki, T | 1 |
| Bresnahan, J; Brown, MA; Cabriales, S; Espina, BM; Gill, PS; Gustafson, NF; Ilaw, M; Louie, S; Orcutt, C; Scadden, DT; Tulpule, A; Winograd, B | 1 |
| Armand, JP; Cunningham, D; Kohne, CH; Misset, JL; van Cutsem, E | 1 |
| Adenis, A; Conroy, T; Paillot, B | 1 |
| Kumazaki, T; Matsukawa, M; Nishiyama, M; Okamoto, R; Park, JS; Sasaki, M; Sekikawa, T; Tanimoto, K; Ukon, K; Yamamoto, W | 1 |
| Cheson, BD | 1 |
10 review(s) available for paclitaxel and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Combined therapy for gastrointestinal carcinomas: exploiting synergies between gene therapy and classical chemo-radiotherapy.
Topics: Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Combined Modality Therapy; Deoxycytidine; Gastrointestinal Neoplasms; Gemcitabine; Genetic Therapy; Humans; Immunotherapy; Paclitaxel | 2015 |
Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cisplatin; Female; Gastrointestinal Neoplasms; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Skin Neoplasms; Teratoma; Treatment Outcome | 2016 |
[Ramucirumab - a new anticancer agent].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Disease-Free Survival; Gastrointestinal Neoplasms; Humans; Paclitaxel; Peritoneal Neoplasms; Prognosis; Ramucirumab; Stomach Neoplasms | 2016 |
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Disease Progression; Enzyme Inhibitors; Gastrointestinal Neoplasms; Gemcitabine; Humans; Paclitaxel; Quinolones; Radiotherapy, Conformal; Treatment Outcome | 2003 |
Intraperitoneal taxanes.
Topics: Antineoplastic Agents, Phytogenic; Biological Availability; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Paclitaxel; Risk Assessment; Sensitivity and Specificity; Taxoids | 2003 |
Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids | 1995 |
New systemic drugs in the treatment of gastrointestinal cancer.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials as Topic; Docetaxel; Gastrointestinal Neoplasms; Humans; Irinotecan; Paclitaxel; Quinazolines; Taxoids; Thiophenes; Thymidylate Synthase | 1996 |
[New anti-cancer drugs for gastrointestinal cancers].
Topics: Amino Acids; Antidotes; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferons; Irinotecan; Leucovorin; Paclitaxel; Taxoids | 1997 |
Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Enzyme Inhibitors; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Platinum; Quinazolines; Taxoids; Thiophenes; Topoisomerase I Inhibitors | 1999 |
[New drugs in gastrointestinal oncology. Current status and future directions].
Topics: Antineoplastic Agents; Camptothecin; Capecitabine; Deoxycytidine; Docetaxel; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Quinazolines; Taxoids; Tegafur; Thiophenes; Vinblastine; Vinorelbine | 1999 |
6 trial(s) available for paclitaxel and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Male; Middle Aged; Neoplasms; Neurofeedback; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Pilot Projects; Platinum Compounds; Survivors; Taxoids; Time Factors; Treatment Outcome; Waiting Lists | 2017 |
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel | 2009 |
Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cholestasis; Drug-Eluting Stents; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Paclitaxel | 2013 |
The activity of paclitaxel in gastrointestinal tumors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Neoplasms; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Survival Rate | 1995 |
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel | 1995 |
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Edema; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Treatment Outcome | 1999 |
17 other study(ies) available for paclitaxel and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Letter.
Topics: Albumins; Fluorouracil; Gastrointestinal Neoplasms; Genotype; Humans; Irinotecan; Leucovorin; Paclitaxel | 2020 |
5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Response.
Topics: Albumins; Fluorouracil; Gastrointestinal Neoplasms; Genotype; Humans; Irinotecan; Leucovorin; Paclitaxel | 2020 |
Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Female; Forkhead Box Protein M1; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterografts; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Mice; Paclitaxel; Stathmin; Tissue Array Analysis | 2021 |
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Gastrointestinal Neoplasms; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pilot Projects; Prospective Studies; Ramucirumab; Survival Analysis; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Burden; Tumor Microenvironment | 2021 |
Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells.
Topics: Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Fatty Acids, Omega-3; Gastrointestinal Neoplasms; Humans; Paclitaxel | 2017 |
Synchronous occurrence of hereditary gastric adenocarcinoma, gastrointestinal stromal tumor, and esophageal small cell and squamous carcinoma in situ: an extremely rare case report.
Topics: Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Lymph Node Excision; Middle Aged; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Stomach Neoplasms; Treatment Outcome | 2017 |
Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Fatigue; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Quality of Life; Self Care; Self Efficacy; Surveys and Questionnaires; Turkey | 2019 |
Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; beta Catenin; Drug Delivery Systems; Epithelial Cell Adhesion Molecule; Gastrointestinal Neoplasms; Gene Knockdown Techniques; HT29 Cells; Humans; Ligands; Male; Mice; Mice, Nude; Micelles; Molecular Docking Simulation; Oligopeptides; Paclitaxel; Peptide Fragments; Phosphatidylethanolamines; Polyethylene Glycols; Protein Binding; Transfection; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |
Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Gastrointestinal Neoplasms; Humans; Intestine, Small; Mice; Nanoparticles; Paclitaxel; Polymers; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Response to nab-paclitaxel plus gemcitabine in a patient with primary resistance to FOLFIRINOX.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel | 2014 |
[Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer].
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Anxiety; Camptothecin; Cognitive Dysfunction; Depression; Drug Therapy, Combination; Fatigue; Female; Fluorouracil; Gastrointestinal Neoplasms; Hemoglobins; Humans; Irinotecan; Male; Memory; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Surveys and Questionnaires; Translating | 2016 |
Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Neoplasms; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thoracic Neoplasms; Treatment Outcome; Urogenital Neoplasms | 2008 |
Drug-eluting stents in malignant biliary obstruction: where do we stand?
Topics: Antineoplastic Agents, Phytogenic; Cholestasis; Drug-Eluting Stents; Female; Gastrointestinal Neoplasms; Humans; Male; Paclitaxel | 2013 |
The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Proliferation; DNA Repair; Gastrointestinal Neoplasms; HT29 Cells; Humans; Paclitaxel; Radiation Dosage; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |
Phase II data on paclitaxel and docetaxel in gastrointestinal malignancies.
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials, Phase II as Topic; Docetaxel; Gastrointestinal Neoplasms; Humans; Paclitaxel; Taxoids | 1996 |
Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers.
Topics: bcl-X Protein; Cell Division; Docetaxel; Ethacrynic Acid; Flow Cytometry; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Genes, p53; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Inhibitory Concentration 50; Isoenzymes; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Taxoids; Time Factors; Transfection; Tubulin; Tumor Cells, Cultured | 2002 |
Clinical trials referral resource. Clinical trials with taxol.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel | 1992 |